Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded with the mission to democratize access to clinical trials, FindMeCure provides a user-friendly platform that helps individuals easily find and apply for participation in future treatment studies. The company aims to bridge the gap between patients seeking advanced treatments and researchers conducting clinical trials. By offering services that simplify the search and application process, FindMeCure focuses on making experimental treatments more accessible to patients worldwide.
Notable figures affiliated with FindMeCure include healthcare professionals and tech experts dedicated to improving patient outcomes through innovative solutions. The platform has garnered attention from investors interested in health tech and patient advocacy. Key achievements include the successful enrollment of numerous patients in clinical trials and partnerships with leading research institutions. FindMeCure's impact lies in its ability to streamline the clinical trial process, thereby accelerating medical research and providing hope to patients with limited treatment options.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Clinical Trials
Technology
HealthTech
Tags
SaaS, Platform
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Patients
Geographic Exposure
Global
When was FindMeCure founded?
FindMeCure was founded in 2015.
Where is FindMeCure's headquarters located?
FindMeCure's headquarters is located in London, GB.
How many employees does FindMeCure have?
FindMeCure has 25 employees as of Feb 4, 2024.
How much has FindMeCure raised to-date?
As of July 05, 2023, FindMeCure has raised a total of $420k (USD) since Jan 5, 2023.
Add Comparison
Total Raised to Date
$420k
USD
Last Update Jan 5, 2023
Current Employees
25
Last updated: Feb 4, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts